** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)

Regulatory Clarification on Deleject Disposable Needle Public Alert

The public Alert No. 042/2026, concerning the reported presence of whitish particulate matter in Deleject Disposable Needle Batch No. 240605, was uploaded onto the NAFDAC website in error. The matter had earlier undergone appropriate regulatory review and investigation and was satisfactorily resolved several months ago. There are currently no quality, safety, or regulatory issues that […]

2026 World Breastfeeding Week Capacity Building Event for Healthcare Professionals

WELCOME REMARKS AND OPENING ADDRESS OF THE DIRECTOR GENERAL NAFDAC AT THE 2026 WORLD BREASTFEEDING WEEK CAPACITY BUILDING EVENT FOR HEALTHCARE PROFESSIONALS HELD ON 11TH AUGUST 2026 AT NAFDAC AUDITORIUM, ISOLO, LAGOS, DELIVERED BY DIRECTOR, FOOD SAFETY AND APPLIED NUTRITION (FSAN) DIRECTORATE, MRS. EVA EDWARDS Protocol It is my distinct pleasure to welcome you all […]

NAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the global community in celebrating World Breastfeeding Week 2026

The National Agency for Food and Drug Administration and Control (NAFDAC) proudly joins the Federal Ministry of Health and Social Welfare, development partners, healthcare professionals, and the global community in celebrating World Breastfeeding Week (WBW) 2026, observed from 1st to 7th August 2026. This year’s theme, “Breastfeeding for a Sustainable Start in Life: Strengthen What Works,” highlights the importance […]

Handling Manufacturer Investigation Reports for Medical Devices and IVDs

Manufacturer Investigation Reports (MIRs) are critical documents used to assess complaints, adverse events, and product quality issues associated with medical devices and in vitro diagnostic (IVD) products. Effective handling of these reports ensures that potential risks to patients and users are promptly identified, investigated, and addressed. The process involves reviewing reported incidents, evaluating root causes, […]

Blacklisting of Onifam Laboratories Ltd

PUBLIC NOTICE ON BLACKLISTING ONIFAM LABORATORIES LTD AND ASSOCIATED PERSONS/ENTITIES FROM PHARMACEUTICAL BUSINESS ACTIVITIES Following NAFDAC investigations, evidence established that Onifam Laboratories Ltd engaged in regulatory misrepresentation, improper use of approvals/certificates, and activities that could compromise product traceability, accountability, and public health. These acts constitute violations of the NAFDAC Act, Cap. N1 LFN 2004, the […]

Public Alert No. 037/2026 – Alert on Suspected Counterfeit Pulmicort® (Budesonide) Inhalation Suspension

The National Agency for Food and Drug Administration and Control (NAFDAC) is informing the public of the detection of a suspected counterfeit medicinal product found in the Nigerian market that infringes on the approved marketing authorization of Pulmicort® (Budesonide) manufactured by AstraZeneca. The information was provided to NAFDAC by AstraZeneca following market surveillance activities. AstraZeneca […]

Public Alert No. 036/2026 – Alert on Suspected Counterfeit Products Mimicking Forxiga® (Dapagliflozin) 

The National Agency for Food and Drug Administration and Control (NAFDAC) is informing the public of the detection of suspected counterfeit medicinal products found in the Nigerian market that infringe on the approved marketing authorization of Forxiga® (dapagliflozin) manufactured by AstraZeneca. AstraZeneca notified NAFDAC following market surveillance activities which identified products bearing names closely resembling […]

Public Alert No. 035/2026 – Alert on the Marketing and Sale of Unregistered Menofix Composition

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the marketing and sale of unregistered Menofix Composition. NAFDAC received a complaint concerning the marketing and sale of Menofix Capsules. The complainant also raised concerns regarding possible liver-related adverse effects associated with some of the ingredients contained in the […]

Public Alert No. 034/2026 – Niger Republic Imposes Import Ban on Bulmex Parboiled Rice from India due to Metallic Contamination

The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed that the Niger Republic’s Ministry of Trade and Industry has banned the importation of Bulmex Parboiled Rice from India. The action was reportedly taken due to concerns raised during an investigation and regulatory oversight by the Agadez Regional Directorate of Commerce […]

End-Of-Pilot Validation, Learning And Dissemination Event of The 2026 Annual Market-Level Large Scale Food Fortification (LSFF) Maiden Digital Monitoring And Compliance Survey

Opening Remarks By The Director-GeneralNAFDAC At The End-Of-Pilot Validation, Learning And Dissemination Event Of The 2026 Annual Market-Level Large Scale Food Fortification (LSFF) Maiden Digital Monitoring And Compliance Survey Held On 18th June 2026 At Bon Hotel Ikeja Residence, Lagos. PROTOCOLS Directors, Heads of Directorates,Deputy Directors,Representative of the Global Alliance for Improved Nutrition (GAIN),Members of […]